Skip to content

Scholar Rock SRRK Interest Expense

Interest Expense at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$49.03M-43.8%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.3M-19.5%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.94M-28.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$23.85M+10.2%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's interest expense?
Scholar Rock (SRRK) reported interest expense of $2.3M in Q1 2026.
How has Scholar Rock's interest expense changed year-over-year?
Scholar Rock's interest expense increased by 26.6% year-over-year, from $1.82M to $2.3M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.